BIOCON LTD. - Intimation regarding purchase of shares in Syngene International Limited by Biocon Research Limited

Biocon Ltd has informed BSE regarding a matter taken up at the meeting of the Board of Biocon Research Limited, a wholly owned subsidiary of the Company held on September 09, 2014.<br/><br/>Biocon Research Limited ("BRL"), a wholly owned subsidiary of Biocon Limited has entered into an agreement with GE Equity International Mauritius, a subsidiary of GE Capital Corporation ("GE Capital"), to purchase the latter's investment in Biocon's research services subsidiary, Syngene International Limited ("Syngene") for an agreed consideration of Rs. 215.38 Crore. GE Capital had a 7.69% stake in Syngene.